Find a company
700,000 people experience heart attack symptoms annually, and will experience the agony of a long wait for test results. Capillary Film Technology (CFT) has developed affordable microfluidic testing technology that allows mass production of simple devices that can test 3 or more biomarkers in a single clinical sample. By measuring multiple cardiac markers, diagnosis of myocardial infarct (heart attack) can be made far more rapidly, not only speeding up treatment but also allowing many people to avoid a worrying and costly hospital stay.
| Project | Capillary Film Technology (CFT) is developing affordable microfluidics for rapid, sensitive, point of care measurement of multiple cardiovascular disease biomarkers |
|---|---|
| Description |
700,000 people experience heart attack symptoms annually, and will experience the agony of a long wait for test results. Capillary Film Technology (CFT) has developed affordable microfluidic testing technology that allows mass production of simple devices that can test 3 or more biomarkers in a single clinical sample. By measuring multiple cardiac markers, diagnosis of myocardial infarct (heart attack) can be made far more rapidly, not only speeding up treatment but also allowing many people to avoid a worrying and costly hospital stay. |
| Funding | £ 913,842 |
| Competition | Competition 5 - Diagnostics and Research tools |
| Competition Date | September 2013 |
| Categories | Cardiovascular |
| Health Innovation Network Partner | Health Innovation Kent Surrey Sussex |
| Website | http://www.capfilmtech.com/ |